Biomedical research is at a turning point. Single cell technologies are opening extraordinary opportunities to address today’s medical challenges. These new tools will enhance our molecular understanding of functional cell states. They will give us major insights into when, how and why diseases of all kinds arise.
Working at the cutting edge of this field, VIB has teamed up with LifeTime, a pan-European research initiative that wants to combine single-cell multi-omics, advanced imaging, artificial intelligence/machine learning and personalized disease models to fundamentally change the current medical practice.
The first edition of Emerging Technologies in Single Cell Research is at the same time VIB’s first virtual conference.
At this virtual edition we will aim that speakers, attendees and exhibitors can interact remotely through a virtual environment, as one of the main goals of the VIB Conference Series is to provide the possibility for networking and collaboration.
At Emerging Technologies in Single Cell research, a two-day virtual conference, VIB and LifeTime will bring together top researchers in the fields of multi-omics and artificial intelligence.
The time zone of the program is CET (Central European Time).
Department of Electrical Engineering and Computer Science, MIT, US; Broad Institute of Harvard and MIT, US; Department of Data Sciences, Dana-Farber Cancer Institute, US
Seeing is sequencing: linking phenotypes and genotypes of heterogeneous cancer cells by high-throughput, microscopy-based single cell selection and functionally annotated single cell sequencing